Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
14.35
+0.99 (7.41%)
Jun 12, 2025, 2:45 PM CST
9.38%
Market Cap 17.42B
Revenue (ttm) 5.16B
Net Income (ttm) 393.03M
Shares Out 1.22B
EPS (ttm) 0.33
PE Ratio 43.95
Forward PE 23.10
Dividend 0.20 (1.50%)
Ex-Dividend Date May 29, 2025
Volume 33,058,504
Average Volume 19,488,618
Open 13.13
Previous Close 13.36
Day's Range 13.13 - 14.38
52-Week Range 9.94 - 14.35
Beta 0.98
RSI 74.24
Earnings Date Aug 15, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinolog... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.